Fortrea Holdings Inc. (FTRE) vs Maravai LifeSciences Holdings, Inc. (MRVI)

Fortrea Holdings Inc. and Maravai LifeSciences Holdings, Inc. are both Biotechnology companies. Fortrea Holdings Inc. and Maravai LifeSciences Holdings, Inc. are of similar size ($2.0B and $1.9B). Fortrea Holdings Inc. grew revenue faster over the last twelve months: −2.09% against −5.03%. Fortrea Holdings Inc. has the higher net margin (−3.18% vs −37.1%) and the higher return on invested capital (−0.48% vs −15.8%). Across the 18 metrics below, Fortrea Holdings Inc. leads on 12 and Maravai LifeSciences Holdings, Inc. on 6.

Valuation

Metric FTRE MRVI Biotechnology median
P/E n/m n/m 7.88
P/S 0.70 5.39 11.47
P/B 3.60 3.16 2.52
Price to free cash flow 9.52 n/m 21.16
EV/EBITDA 41.06 n/m 0.74
EV/Sales 1.04 5.90 10.73
Earnings yield (4.58%) (6.84%) (28.84%)
Free cash flow yield 10.50% (3.19%) (23.03%)

Profitability

Metric FTRE MRVI Biotechnology median
Gross margin 19.30% 34.89% 65.16%
Operating margin (0.40%) (56.08%) 0.00%
Net margin (3.18%) (37.07%) 0.00%
Free cash flow margin 7.40% (17.17%) 0.00%
Return on equity (15.30%) (18.79%) (57.72%)
Return on assets (3.07%) (10.31%) (49.22%)
Return on invested capital (0.48%) (15.83%) 0.00%

Growth

Metric FTRE MRVI Biotechnology median
Revenue growth (TTM) (2.09%) (5.03%) 5.64%
EPS growth (last fiscal year) (194.55%) 14.29% —
Revenue growth, 5-year CAGR 1.09% (8.15%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FTRE MRVI Biotechnology median
Debt to equity 2.01 0.50 0.00
Current ratio 0.96 4.05 4.73
Net debt to EBITDA 266.13 (0.69) 0.96

Dividend

Metric FTRE MRVI Biotechnology median
Dividend yield — 0.26% 2.10%
Payout ratio — 0.00 0.00

Size

Metric FTRE MRVI Biotechnology median
Market cap 1.90b 1.99b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack